Navigation Links
International Probiotics Association Objects to Media Depiction of AAD/CDD Study, Provides Further Insight to Study Results
Date:8/14/2013

Zurich, Switzerland (PRWEB) August 14, 2013

In a recently published study, Allen and co-workers (2013) report on a specific probiotic preparation to reduce the incidence and/or duration of antibiotic associated diarrhea (AAD) and Clostridium difficile diarrhea (CDD). Despite the null outcome, the authors should be congratulated with performing the largest study of its kind to date, consisting of almost 3,000 participants. The International Probiotics Association (IPA), however, would like to point out several design issues with the study that would impact the authors’ general conclusions.

The first issue is the broad and sweeping interpretation by the authors stating that “…no evidence that a multi-strain preparation of lactobacilli and bifidobacteria was effective in prevention of AAD or CDD.” This is not appropriate given that there are a variety of species and strains within the two genera. The article also does not mention that the product used in the study is commercially available. A previous article with the study protocol does provide such information (Allen et al. 2012). A previous study had shown that the same product reduced the incidence of CDD (Plummer et al. 2004) and appears to influence the microbiota composition when challenged by antibiotics (Plummer et al. 2005; Madden et al. 2005). Instead of discussing probiotics and AAD in general, why were such contradicting findings of the same product not discussed in the recent paper (Allen et al. 2013)?

One also cannot dismiss the numerous studies using different single and multi-strain probiotic combinations in a variety of delivery systems (e.g. supplement capsule, powder or yogurt) that also dispute the findings of Allen, et al. (2013) and show efficacy against AAD, as well as CDD (Hempel et al. 2012; Johnston et al. 2012; Rogers et al. 2013; Goldenberg et al. 2013).

The second issue is how the study was described by some media outlets: The study is a ‘null’ study and not a ‘negative’ study as the accompanying commentary suggests (Daneman 2013). A recent meta-analysis (Hempel et al. 2012) on the effect of probiotics on AAD lists 17 ‘null’ studies (out of 63). So, a ‘null’ study is nothing new; although admittedly, the present study is by far the largest of its kind.

Because of the scale of the study – 17,420 patients were assessed for eligibility, and 2,981 were randomized – the researchers had to follow some practical procedures:

  •     Some subjects were recruited despite the fact that they were already on antibiotic therapy for up to a week. As such, it is not clear as to how many subjects were already using antibiotics prior to receiving the study’s probiotic preparation. Most previous probiotic-AAD studies have commenced probiotic supplementation at the start of antibiotic treatment or prior to (e.g. Helicobacter eradication therapy).
  •     Eligible patients could be using either oral or intravenous antibiotics; past studies have focused mainly on oral antibiotics or at least one route of administration. The recruitment of both oral and intravenous antibiotic users may have added to the variability.
  •     The procedure also called for probiotic administration for a fixed time (three weeks.) Supplementation with probiotics in previous studies has usually lasted at least up to the end of the antibiotic treatment, but often longer. In the present study, one third of the subjects had antibiotic therapy for at least 14 days – did they receive probiotics up to the end of the antibiotic therapy?

Again, from a practical perspective, it is understandable that the researchers have designed the study this way; but it may help explain the null results.

Another interesting point that may have contributed to the reported results is the lower than expected incidence of AAD and CDD: The expected incidence of AAD and CDD was 20% and 4% respectively, in the placebo group. But in reality, it was 10.6% and 0.99% respectively, overall, which means the study was grossly underpowered; therefore, any positive effect of the probiotics would be lost upon statistical analysis. So despite this being the largest study of its kind, ironically there were actually not enough subjects in the study or enough events to make a meaningful analysis of the potential benefits of the therapy. Regardless, the low incidence of AAD and CDDs was good news from the patients’ perspective. Based on the results, perhaps an important and very positive finding that may have been missed was the fact that AAD and CDD are not as prevalent as generally thought.

In conclusion, IPA feels the results of the study could have been better articulated with a tighter scope on the study’s findings: “…this large study did not reproduce, the same, statistically significant, positive effect seen previously for the same microbial preparation for the prevention of AAD and CDD in the elderly.”

About the International Probiotics Association:
The International Probiotics Association is an international organization with members comprised of both industry and academia. Its goal is to provide a unique and global forum for the exchange of research and the latest breakthroughs in probiotic technology and product development. The International Probiotics Association also works with government bodies and industry to assist in establishing scientific standards for probiotic supplements, probiotic pharmaceutical products and functional foods. The International Probiotics Association educates consumers on the proven health benefits of probiotics for humans and animals by attending trade shows, health tours and other media functions such as internet blogs etc. The International Probiotics Association holds a Non-Governmental Organization (NGO) observer status within Codex Alimentarius.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11028707.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCSB to host international conference on autism intervention and treatment
2. SafeToSleep Baby Monitor Wins International Innovation Award
3. OMICS Group USA Announces Its International Conferences 2013-2014
4. Jusuru® International Appoints Shirley Meredith as New Vice President of iRep Experience
5. Mr. Carmine’s International Hair Salon Announces Launch of New Website and Digital Partnership with The Daily News
6. BioProcess International Latest Issue Now Available Online and in the App Store
7. Sofia University Professor Dr. Kris Brandenburger Receives International Education Faculty Achievement Award
8. Worldwide Power Products Arranges Expedited Delivery of Kato Generator End to Leading Oilfield Services Firm Ensign International Energy Services
9. International Honor for Scholars Assisted by 360 Dissertation
10. International Labour Organization Official Joins the Microcredit Summit Campaign Executive Committee
11. International Fitness Celebrity Jennifer Nicole Lee Will Be Featured as a Top Presenter & Group Instructor at the World Famous Fitness Celebrity Festival Sweat Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... 2016 , ... In honor of National Physical Fitness and Sports Month in ... their fitness journey on social media. , The foot care company, which specializes ... product voucher each week during May to one winner. , “Whether the goal is ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... Huntington Beach, California announced today the release of Grow Healthy Vending’s newly revamped ... one of the fastest growing healthy vending providers in North America with locations ...
(Date:5/2/2016)... ... 2016 , ... Over $60 Billion is spent annually on products for our ... product review site for Toys, Tots, Pets & More (TTPM) announced the 15 winners ... at the Metropolitan Pavilion in New York City. , Chosen from a field of ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... MedPro Waste ... mail back service. MedPro now offers its mail back service for an all-inclusive ... we are now able to provide service to all of the clients in the ...
(Date:5/2/2016)... ... May 02, 2016 , ... Further establishing itself as ... that the new WHIMZEES Variety Value Boxes were selected from over 1,000 entrants as ... Award. , WHIMZEES natural dental chews for dogs are a favorite product among ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... Life Sciences, Product Development Capabilities in ... Customer Base . Indegene ( ... announced the acquisition of Skura Corporation,s life science ... in adaptive sales enablement technology for life science ...
(Date:4/28/2016)... YORK , April 28, 2016  While ... notably complement the company,s valve repair and stent ... move also places Abbott more firmly into patient ... of the fastest growing device areas, with double-digit ... its recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... , April 28, 2016 ... consumer insights on healthcare, announced today that it has ... report Cool Vendor in Life Sciences, 2016, ... 15, 2016.  The report focuses on life-science- oriented analytics, ... insight from patients and doctors, confirm medication ingestion, and ...
Breaking Medicine Technology: